Programs

Ongoing

Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma (GEA)

On-Demand

We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to better understand established and emerging data related to HER2-targeted therapies in GEA. This on-demand course is available for continuing education credit until 3/29/25.

Connecting With the Experts at ASCO 2024 Clinical Pearls and Data Insights About  Anti-HER2 Therapies in Biliary Tract Cancer

On-Demand

We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to better conceptualize the new and emerging data related to HER2-targeted therapies in BTC and gastric cancer (GC). This on-demand course is available for continuing education credit until 6/25/25.

cross linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram